Abstract
Hepatoblastoma is the most common primary liver tumor in children, accounting for 79% of pediatric liver malignancies in children younger than 15 years, with most cases reported before the age of 5 years. Localization of primary and recurrent disease is necessary for appropriate clinical decision-making and treatment. We present a case of recurrent hepatoblastoma heralded by rising alpha-fetoprotein levels. After unsuccessful localization by conventional CT and MRI, positron emission tomography CT imaging localized the sites of recurrence.
Similar content being viewed by others
References
Herzog CE, Andrassy RJ, Eftekhari F (2000) Childhood cancers: hepatoblastoma. Oncologist 5:445–453
Fuchs J, Rydzynski J, Von Schweinitz D, et al (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95:172–182
Matsunaga T, Sasaki F, Ohira M, et al (2003) Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 19:142–146
Shulkin BL (1997) PET applications in pediatrics. Q J Nucl Med 41:281–291
Wong KK, Lan LC, Lin SC, et al (2004) The use of positron emission tomography in detecting hepatoblastoma recurrence—a cautionary tale. J Pediatr Surg 39:1779–1781
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Figarola, M.S., McQuiston, S.A., Wilson, F. et al. Recurrent hepatoblastoma with localization by PET-CT. Pediatr Radiol 35, 1254–1258 (2005). https://doi.org/10.1007/s00247-005-1568-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-005-1568-6